Literature DB >> 15017077

Systemic delivery of synthetic siRNAs.

Mouldy Sioud1, Dag R Sørensen.   

Abstract

The ability to regulate endogenous gene expression by cleaving mRNA is important in basic and applied biological research. This is now driven predominantly by small interfering RNAs (siRNAs) as they induce sequence-specific gene silencing. However, the major obstacle to the use of siRNAs as therapeutics is the difficulty involved in effective in vivo delivery. This chapter describes the liposomal delivery of siRNAs into adult mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15017077     DOI: 10.1385/1-59259-746-7:515

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  The apoptotic pathway as a therapeutic target in sepsis.

Authors:  Doreen E Wesche-Soldato; Ryan Z Swan; Chun-Shiang Chung; Alfred Ayala
Journal:  Curr Drug Targets       Date:  2007-04       Impact factor: 3.465

2.  Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.

Authors:  M Mikhaylova; I Stasinopoulos; Y Kato; D Artemov; Z M Bhujwalla
Journal:  Cancer Gene Ther       Date:  2008-10-17       Impact factor: 5.987

Review 3.  RNA interference: from gene silencing to gene-specific therapeutics.

Authors:  Ray K M Leung; Paul A Whittaker
Journal:  Pharmacol Ther       Date:  2005-08       Impact factor: 12.310

4.  Gene silencing by RNAi in mouse Sertoli cells.

Authors:  Emilio González-González; Pedro P López-Casas; Jesús Del Mazo
Journal:  Reprod Biol Endocrinol       Date:  2008-07-11       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.